Godavari Biorefineries Intrinsic Value
Godavari Biorefineries intrinsic value. Godavari Biorefineries (GODAVARIB) median intrinsic value is ₹153.33 from 3 valuation models (range ₹90–₹272), vs current price ₹224.91 — -31.8% downside (Trading Above Calculated Value), margin of safety -46.7%. Read GODAVARIB ex-dividend dates for the complete payout history and dividend yield track record.
GODAVARIB Valuation Methods Summary — DCF, Graham Number & P/E
Godavari Biorefineries intrinsic value across 3 models vs current price ₹224.91 — upside/downside and value range per method. Compare with GODAVARIB fair value to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹153.33 | ₹138.00 - ₹168.66 | -31.8% | Book Value/Share: ₹153.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹272.31 | ₹245.08 - ₹299.54 | +21.1% | Revenue/Share: ₹340.39, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹89.96 | ₹71.97 - ₹107.95 | -60.0% | CF Growth: 5.0%, Discount: 15% |
GODAVARIB Intrinsic Value vs Market Price — All Valuation Models
Godavari Biorefineries fair value range ₹90–₹272 vs current market price ₹224.91 across 3 valuation models. For current market price and key ratios, visit Godavari Biorefineries share price chart.
GODAVARIB Intrinsic Value Analysis — Undervalued or Overvalued?
Godavari Biorefineries median intrinsic value ₹153.33, current price ₹224.91 — Trading Above Calculated Value by 31.8%, margin of safety -46.7%.
What is the intrinsic value of GODAVARIB?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Godavari Biorefineries (GODAVARIB) is ₹153.33 (median value). With the current market price of ₹224.91, this represents a -31.8% variance from our estimated fair value.
The valuation range spans from ₹89.96 to ₹272.31, indicating ₹89.96 - ₹272.31.
Is GODAVARIB undervalued or overvalued?
Based on our multi-method analysis, Godavari Biorefineries (GODAVARIB) appears to be trading above calculated value by approximately 31.8%.
GODAVARIB Financial Health — Key Ratios vs Industry Benchmarks
Godavari Biorefineries financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.54 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -21.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.89x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
GODAVARIB Cash Flow Quality — Operating & Free Cash Flow
Godavari Biorefineries operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹6 Cr | ₹-29 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹185 Cr | ₹163 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹197 Cr | ₹90 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹45 Cr | ₹21 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹130 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |